Skip to main content
. 2018 Jun 22;11:303–312. doi: 10.2147/DMSO.S145862

Table 5.

Comparison of FBS and lipids at baseline and 12 weeks between intervention group (n=66) and control group (n=64)

Measure Baseline mean (SD) 12 weeks from baseline, mean (SD) Cohen’s d p
G T G vs T
FG Intervention 96.82±7.55 93.83±5.87 0.44 0.16 <0.005 <0.005
Control 95.90±8.65 95.97±7.55
0.46 (−1.54 to 3.37) 0.01 (−6.32 to −1.83) F=1.99 F=19.45 F=37.28
TC Intervention 187.25±25.31 182.38±24.31 0.19 0.53 <0.005 <0.005
Control 186.57±21.48 186.42±18.70
0.13 (−2.15 to 15.28) 0.74 (−9.48 to 6.81) F=0.38 F=36.88 F=45.84
HDL Intervention 39.80±5.77 41.40±5.44 0.28 0.04 0.02 0.006
Control 41.40±5.44 40.28±5.52
0.10 (−0.39 to 3.99) <0.005 (2.42 to 6.56) F=8.72 F=40.15 F=62.00
LDL Intervention 118.29±25.96 113.28±25.59 0.19 0.62 <0.005 <0.005
Control 116.54±28.96 117.23±28.33
0.93 (−10.02 to 10.96) 0.28 (−15.83 to 4.68) F=0.23 F=32.62 F=40.73
TG Intervention 106.27±26.65 99.32±25.99 0.26 0.19 <0.005 <0.005
Control 107.08±22.75 108.09±22.66
1.00 (−9.41 to 9.41) 0.008 (−20.97 to −3.19) F=1.73 F=16.32 F=81.74

Abbreviations: FBS, fasting blood sugar; TC, total cholesterol; HDL, high-density lipoprotein; LDL, low-density lipoprotein; TG, triglycerides.